Summit Therapeutics Inc. ( SMMT) - Key Metrics
SMMT Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | -$0.29 | -$0.13 | -$0.13 |
| 2025Q3 | ? | -$0.31 | -$0.13 | -$0.13 |
| 2025Q2 | ? | -$0.76 | -$0.09 | -$0.09 |
| 2025Q1 | ? | -$0.09 | -$0.08 | -$0.08 |
SMMT Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -14.92 |
| 2025Q3 | ? | -16.57 |
| 2025Q2 | ? | -6.98 |
| 2025Q1 | ? | -56.58 |
SMMT
Price: $14.32
52 week price:
Earnings Per Share: -1.59 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 252593
Ebitda: -3.9 millionMarket Capitalization: 11.7 billion